Researchers from the National Surgical Adjuvant Breast and Bowel Project (NSABP) who conducted the landmark Breast Cancer Prevention Trial (BCPT), report a seven-year and final update of the trial results in the November 16, 2005, Journal of the National Cancer Institute*. In this final report, reductions in breast cancer incidence among participants taking tamoxifen were […]

A new study suggests that ovarian tumors classified as serous borderline or low malignant potential (LMP) are not early precursors in the development of aggressive ovarian cancer, but may instead be part of an entirely different class of tumors. Furthermore, genes that were identified in this study as being expressed, or active, in these different […]

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), today announced a cancer biorepository pilot project designed to standardize biospecimen collection and management among investigators of the NCI’s prostate cancer SPOREs (Specialized Programs of Research Excellence). The project will enhance the quality and availability of various biospecimens and associated data for […]

A new study from the National Cancer Institute (NCI), part of the National Institutes of Health, shows that currently available screening methods such as transvaginal ultrasound (TVU) and testing for a protein biomarker called CA-125, alone or in combination, can detect ovarian cancer but can also produce many false-positive test results, causing needless surgery. This […]

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has announced the appointment of Kishor Bhatia, Ph.D., as director of the new AIDS Malignancy Program (AMP). Bhatia has served as the program director for the Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, since 2004 and his appointment to AMP […]